Atlas Trials

Adaptimmune

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Adaptimmune

RecordFirmDate
ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) (NCT04752358)Adaptimmune2021-09-15
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer (NCT06048705)Adaptimmune2021-03-09
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors (NCT04526509)Adaptimmune2020-12-21
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma (NCT05943990)Adaptimmune2020-12-21
SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer (NCT04408898)Adaptimmune2020-07-02
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors (NCT03391791)Adaptimmune2018-02-28

Track Adaptimmune automatically

Every clearance here is in the API, with alerts when new ones post.